Nod Law

Neugeboren O'Dowd PC, operating as Nod Law, is an intellectual property-focused law firm headquartered in Louisville, Colorado, serving the Denver/Boulder metropolitan area. The firm maintains a single office location but describes its practice as global, leveraging an expansive network of foreign associates to assist clients with domestic and international patent and trademark issues. While no AmLaw or Chambers rankings for Nod Law were reliably sourced, its single office and described size suggest it operates as a regional IP boutique. The firm's team includes approximately 9 attorneys with additional paralegal support.

Nod Law specializes in all aspects of intellectual property protection, technology-focused transactions, and commercial litigation, with a significant emphasis on patent litigation. The firm's IP litigation practice covers a broad range of technology areas, including medical and life sciences, artificial intelligence, hardware and semiconductors, software, consumer products, and robotics. Their litigation services encompass initial case analysis, damages assessment, discovery, expert witness engagement, and trial proceedings.

Based on available tracked case data, Nod Law has appeared exclusively on the plaintiff side in its lone recorded patent litigation matter. The firm represented Haemonetics Corporation as local counsel in Haemonetics Corporation v. Terumo BCT, Inc. (D. Colo. 1:25-cv-01409), a patent infringement case filed in May 2025. In this case, Haemonetics alleged willful infringement of several patents, including U.S. Patent No. 11,738,124, related to plasma systems. The litigation is ongoing, with a scheduling order issued in September 2025.

The firm is also engaged in Post-Grant Review (PGR) and Inter Partes Review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). In the Haemonetics matter, Nod Law's client, Haemonetics Corporation, was involved in IPR2025-01374, where the PTAB Director denied Terumo BCT, Inc.'s request for discretionary denial of an IPR petition concerning U.S. Patent No. 11,738,124. This demonstrates the firm's capability in defending patent owners in PTAB actions.

Key partners involved in the firm's IP litigation and patent practice include Carolyn Valerie Juarez, who served as local counsel in the Haemonetics district court case and is active in diverse intellectual property litigation matters. Senior Partner Craig A. Neugeboren, the firm's founder, and Senior Partner Sean O'Dowd also play significant roles in patent counseling, procurement, and litigation support. Partner Shane Percival contributes to IP litigation support, alongside patent and trademark procurement.